Cannabis analytics

Medical cannabis analytics: precision and compliance at the highest level

Contact us

Since QMEDIS Analytics was founded in March 2021, we have focused on analytics related to medical cannabis: whether in the form of cannabis flowers, cannabis extracts, or as pure substances such as tetrahydrocannabinol (THC) or cannabidiol (CBD), as well as alternative dosage forms.

As a GMP-certified testing laboratory with the appropriate manufacturing license for quality control analysis of non-sterile drugs and phytopharmaceuticals, we carry out our analyses in the context of cannabis analysis in accordance with the European Pharmacopoeia (Ph. Eur.), the requirements of the German Pharmacopoeia (DAB), and the German Drug Codex (DAC). Our range of services includes all relevant tests to ensure batch-specific approval and marketability of medical cannabis.

Our goal is to support you as a manufacturer, importer, and distributor of cannabis flowers and cannabis extracts in reliably meeting the high regulatory requirements for the quality and safety of these medicinal products and active ingredients.

Our range of analyses for medical cannabis

We offer a comprehensive range of tests for cannabis flowers, extracts, dronabinol, cannabidiol, and medicines made from them. All tests are carried out in accordance with the applicable monographs and guidelines:

Identity

  • Microscopic identification of cannabis flowers (Ph. Eur. 2.8.23)
  • Macroscopic examination of cannabis flowers (Ph. Eur.)
  • Thin-layer chromatography (TLC) in accordance with Ph. Eur. 2.2.25

Content

  • Quantitative determination of the main cannabinoids THC, THCA, CBD, CBDA and others in accordance with Ph. Eur. 2.2.29

Purity

  • Quantitative determination of CBN according to Ph. Eur. 2.2.29
  • Foreign substances in cannabis flowers according to Ph. Eur. 2.8.2
  • Loss on drying of cannabis flowers according to Ph. Eur. 2.2.32
  • Water content in cannabis extracts according to Ph. Eur. 2.5.12
  • Residual solvents in cannabis extracts according to Ph. Eur. 5.4
  • Relative density in cannabis extracts according to Ph. Eur. 2.2.5
  • Pesticide residues according to Ph. Eur. 2.8.13
  • Heavy metal analysis according to Ph. Eur. 2.4.27: Arsenic, Lead, Cadmium, Mercury
  • Aflatoxins B1, B2, G1 & G2 according to Ph. Eur. 2.8.18
  • Ochratoxin A according to Ph. Eur. 2.8.22
  • Microbiology according to Ph. Eur 5.1.4 or 5.1.8: TAMC, TYMC, E.coli, Bile salt-tolerant, Gram-negative bacteria, Salmonella, Staphylococcus aureus, Pseudomonas aeruginosa

Why QMEDIS Analytics?

  • Extensive experience in the analysis of cannabis-based medicines and active ingredients
  • Certified quality management system
  • Fast turnaround times and close communication with our customers
  • Advice on regulatory issues

With QMEDIS Analytics, you get analytical excellence—for maximum safety, quality, and compliance. Find out how we can reliably and efficiently support your medical cannabis project.